-
[ 13-Jun-2010 ] Merck drug improves sleep in insomnia study
The drug, MK-4305, helped patients sleep for a larger percentage of eight hours spent in bed at one night and at the end of four weeks of treatment, Merck said. The drug also demonstrated superiority to placebo in the time it took to fall asleep and time…
-
[ 13-Jun-2010 ] Sleepless nights for Somaxon: Will it find a partner for its insomnia drug?
On March 18, 2010, Somaxon Pharmaxeuticals (SOMX) was granted FDA approval to sell Silenor 3 and 6 mg. tablets for the treatment of insomnia characterized by difficulty with sleep maintenance. This approval was met with a stock price move from 4 to 10…
-
[ 30-Mar-2010 ] Causes of sleep apnea, insomnia and other sleeping disorders
Here’s an extract of an interview with Dr. Lisa Williams of Montgomery Pulmonary Consultants. She regularly sees people in sleep labs suffering from sleep apnea and insomnia.
-
[ 26-Mar-2010 ] Imovane (zopiclone) vs. Lunesta (eszopiclone)
We sometimes get emails wondering about the difference between Lunesta (eszopiclone) and Imovane (zopiclone). Since both of these medications share the same original maker - Sepracor (and the same atoms apparently), it’s understandable that many are…
-
[ 21-Mar-2010 ] Sleep medications: Zopiclone (Somnosan, Imovane, Lipovan, Ximovan, Datolan)
Zopiclone is the generic name of a prescription sleep aid developed by Sepracor and introduced in 1988. Zopiclone helps you get to sleep faster and sleep with fewer interuptions. It is available in about 85 countries worldwide and marketed under various…
Page 1 of 1 pages
|
